Microsoft word - bhri publications 2006

Baker Heart Research Institute
2006 Publications Listing
Journal Articles
Adams DJ, Head GA, Markus MA, Lovicu FJ, van der Weyden L, Kontgen F, Arends MJ, Thiru S, Mayorov DN, Morris BJ. Renin enhancer is critical for control of renin gene expression and cardiovascular function. J Biol Chem 2006;281(42):31753-61. Ahimastos AA, Lawler A, Reid CM, Blombery PA, Kingwell BA. Ramipril markedly improves walking ability in patients with peripheral arterial disease. Ann Intern Med 2006;144(9):660-4. Ahrens IG, Moran N, Aylward K, Meade G, Moser M, Assefa D, Fitzgerald DJ, Bode C, Peter K. Evidence for a differential functional regulation of the two β3-integrins αVβ3 and αIIbβ3. Exp Cell Res 2006;312(6):925-37. Ajani AE, Szto G, Duffy SJ, Eccleston D, Clark DJ, Lefkovits J, Chew DP, Warren R, Black A, New G, Walton A, Lew R, Shaw J, Horrigan M, Sebastian M, Yan BP, Brennan A, Meehan A, Reid C, Krum H; Melbourne Interventional Group investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 2006;15(1):44-7. Allen AM, Dosanjh J, Dassanayake S, Tan G, Thomas WG. Baroreceptor reflex stimulation does not induce cytomegalovirus promoter-driven transgene expression in the ventrolateral medulla in vivo. Auton Neurosci-Basic Clin 2006;126-127(1-2):150-5. Allen AM, Dosanjh JK, Erac M, Dassanayake S, Hannan RD, Thomas WG. Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension 2006;47(6):1054-61. Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GEO, Gustafson TA. Halofenate is a selective peroxisome proliferator–activated receptor γ modulator with antidiabetic activity. Diabetes 2006;55(9):2523-33. Alvarenga ME, Richards JC, Lambert G, Esler MD. Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med 2006;68(1):8-16. Amira C, Ntyintyane L, Wilkinson D, Stewart S, Becker A, Libhaber E, Silwa K. Emerging epidemic of cardiovascular disease among urban Africans: acute coronary syndrome at Baragwanath Hospital, Soweto. SA Heart 2006;3(4):7-12. Battaglia S, Angus P, Chin-Dusting JPF. Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol 2006;21(7):1189- Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295(2):180-9. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang PM, Izumo S, Pu WT. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 2006;103(39):14471-6. Bobik A. Transforming growth factor-βs and vascular disorders. Arterioscler Thromb Vasc Biol 2006;26(8):1712-20. Bukrinsky M, Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. J Leukoc Biol 2006;80(5):1044-51. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;17(9):2484-94. Calkin AC, Allen TJ. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention. Am J Cardiovasc Drugs 2006;6(1):15-40. Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia 2006;49(4):766-74. Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-α and γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 2006;21(9):2399-405. Capewell S, Murphy NF, MacIntyre K, Frame S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, McMurray JJ. Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study. Heart 2006;92(11):1563-70. Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA. Discordant gene expression in skeletal muscle and adipose tissue of patients with Type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 2006;49(5):1000-7. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, Kemp BE, Petersen BK, Febbraio MA. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006;55(10):2688-97. Chan HW, Jenkins A, Pipolo L, Hannan RD, Thomas WG, Smith NJ. Effect of dominant-negative epidermal growth factor receptors on cardiomyocyte hypertrophy. J Recept Signal Transduct Res 2006;26(5-6):659-77. Chan HW, Smith NJ, Hannan RD, Thomas WG. Tackling the EGFR in pathological tissue remodelling. Pulm Pharmacol Ther 2006;19(1):74-8. Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell BA, Dart AM. Effect of dietary supplementation with β-casein A1 or A2 on markers of disease development in persons at high risk of cardiovascular disease. Br J Nutr Clark RA, Yallop J, Wickett D, Krum H, Tonkin A, Stewart S. Nursing sans frontières: a three year case study of multi-state registration to support nursing practice using information technology. Aust J Adv Nurs 2006;24(1):39-45. Cooper ME. Is diabetic nephropathy disappearing from clinical practice? Pediatr Cooper ME, Tikellis C, Thomas MC. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. J Hypertens Suppl 2006;24(1):S57-63. Dart AM, Gatzka CD, Kingwell B. Letter by Dart et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study". Circulation 2006;114(15):e537. Dart AM, Gatzka CD, Kingwell BA, Jennings GL. Response to brachial and central arterial pressure. Hypertension 2006;48(1):e2. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang Yu-Lu, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ. Brachial blood pressure but not central arterial waveforms predict future cardiovascular events in elderly female hypertensives. Hypertension 2006;47(4):785-90. Dawson M, Mariani JA, Koulouris G, Taylor AJ, Avery S. The successful treatment of primary cardiac lymphoma with a dose dense schedule of rituximab-plus-CHOP. Ann Oncol 2006;17(1):176-7. de Dios ST, O’Brien RC, Little PJ. Clinical thiazolidinediones as PPARγ ligands with the potential for the prevention of cardiovascular disease in diabetes. Curr Diab Rev 2006;2(2):227-39. de Haan JB, Witting PK, Stefanovic N, Pete J, Daskalakis M, Kola I, Stocker R, Smolich JJ. Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J Lipid Res 2006;47(6):1157-67. De Matteo R, Head GA, Mayorov DN. Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits. Am J Physiol Regul Integr Comp Physiol 2006;290(1):R257-64. De Matteo R, Head GA, Mayorov DN. Tempol in the dorsomedial hypothalamus attenuates the hypertensive response to stress in rabbits. Am J Hypertens de Zeeuw D, Lewis EJ, Remuzzi G, Brenner BM, Cooper ME. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006;367(9514):899-900. Di Nicolantonio R, Kostkal V, Kwitek A, Jacob H, Thomas WG, Harrap SB. Fine mapping of Lvm1: a quantitative trait locus controlling heart size independently of blood pressure. Pulm Pharmacol Ther 2006;19(1):70-3. Ditiatkovski M, Toh BH, Bobik A. GM-CSF deficiency reduces macrophage PPAR-γ expression and aggravates atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2006;26(10):2337-44. Douglas G, Armitage JA, Taylor PD, Lawson JR, Mann GE, Poston L. Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat. J Physiol 2006;571(2):477-87. Driscoll A, Worrall-Carter L, McLennan S, Dawson A, O'Reilly J, Stewart S. Heterogeneity of heart failure management programs in Australia. Eur J Cardiovasc Nurs 2006;5(1):75-82. Driscoll A, Worrall-Carter L, Stewart S. Rationale and design of the National Benchmarking and Evidence-based National Clinical Guidelines for Chronic Heart Failure Management Programs Study. J Cardiovasc Nurs 2006;21(4):276-82. Du XJ, Fang L, Kiriazis H. Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 2006;111(2):434-75. Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM. Transgenic α1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res 2006;71(4):735- Duffy SJ, Federman J, Farrington C, Reuter DG, Richardson M, Kaye DM. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure. Catheter Cardivasc Interv 2006;68(2):205-10. Earley MJ, Showkathali R, Alzetani M, Kistler PM, Gupta D, Abrams DJ, Horrocks JA, Harris SJ, Sporton SC, Schilling RJ. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Eckert KA, Wilkinson D, Taylor AW, Stewart S, Tucker GR. A population view of mental illness in South Australia: broader issues than location. Rural Remote Health 2006;6(2):541. Eikelis N, Esler M, Barton D, Dawood T, Wiesner G, Lambert G. Reduced brain leptin in patients with major depressive disorder and in suicide victims. Mol Psychiatr 2006;11(9):800-1. El-Osta, A. Mechanisms of abnormal gene expression in tumor cells. EXS 2006;96:351-61. Esler M, Alvarenga M, Pier C, Richards J, El-Osta A, Barton D, Haikerwal D, Kaye D, Schlaich M, Guo L, Jennings G, Socratous F, Lambert G. The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J Psychopharmacol 2006;20(4 Suppl):60-6. Esler M, Eikelis N. Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol 2006;100(1):11-2. Esler M, Kaye D. Sympathetic nervous system neuroplasticity. Hypertension Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension Esler M, Wiesner G. Development of the metabolic syndrome along the female biological life-path. J Hypertens 2006;24(1):43-5. Farrell MJ, Egan GF, Zamarripa F, Shade R, Blair-West J, Fox P, Denton DA. Unique, common, and interacting cortical correlates of thirst and pain. Proc Natl Acad Sci USA 2006;103(7):2416-21. Fischer CP, Hiscock NJ, Basu S, Vessby B, Kallner A, Sjoberg LB, Febbraio MA, Pedersen BK. Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans. J Appl Physiol 2006;100(5):1679-87. Gallicchio MA, McRobert A, Tikoo A, Cooper ME, Bach LA. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner. J Am Soc Nephrol 2006;17(2):414-21. Gao XM, Wong G, Wang B, Kiriazis H, Moore XM, Su YD, Dart AM, Du XJ. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006;24(8):1663-70. Garbrecht MR, Krozowski ZS, Snyder JM, Schmidt TJ. Reduction of glucocorticoid receptor ligand binding by the 11-β hydroxysteroid dehydrogenase type 2 inhibitor, Thiram. Steroids 2006;71(10):895-901. Garbrecht MR, Schmidt TJ, Krozowski ZS, Snyder JM. 11β-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites. Am J Physiol Endocrinol Metab 2006;290(4):E653-60. Garreffa AM, Woodman OL, Cao AH, Ritchie RH. Sodium nitroprusside protects adult rat cardiac myocytes from cellular injury induced by simulated ischemia: role for a non-cGMP-dependent mechanism of nitric oxide protection. J Cardiovasc Pharmacol 2006;47(1):1-8. Giunti S, Barit D, Cooper ME. Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med 2006;97(3):241-62. Giunti S, Barit D, Cooper ME. Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 2006;48(4):519-26. Giunti S, Cooper M. Management strategies for patients with hypertension and diabetes: why combination therapy is critical. J Clin Hypertens 2006;8(2):108-13. Gordon MV, Calkin AC. Vildagliptin: a viewpoint by Michelle V. Gordon and Anna C. Calkin. Drugs 2006;66(15):2002-4. Gosbell AD, Stefanovic N, Scurr LL, Pete J, Kola I, Favilla I, de Haan JB. Retinal light damage: structural and functional effects of the antioxidant glutathione peroxidase-1. Invest Ophthalmol Vis Sci 2006;47(6):2613-22. Gould PA, D'Agostino J, Schneider HG, Kaye DM. Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure. Eur J Heart Fail 2006;8(3):263-9. Gould PA, Mariani JA, Kaye DM. Biventricular pacing in heart failure: a review. Expert Rev Cardiovasc Ther 2006;4(1):97-109. Gould PA, Yii M, McLean C, Finch S, Marshall T, Lambert GW, Kaye DM. Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation. Pacing Clin Electrophysiol 2006;29(8):821-9. Gupta D, Al-Lamee RK, Earley MJ, Kistler P, Harris SJ, Nathan AW, Sporton SC, Schilling RJ. Cryoablation compared with radiofrequency ablation for atrioventricular nodal re-entrant tachycardia: analysis of factors contributing to acute and follow-up outcome. Europace 2006;8(12):1022-6. Hadj A, Esmore D, Rowland M, Pepe S, Schneider L, Lewin J, Rosenfeldt F. Pre-operative preparation for cardiac surgery utilising a combination of metabolic, physical and mental therapy. Heart Lung Circ 2006;15(3):172-81. Harikrishnan KN, Pal S, Yarski M, Baker EK, Chow MZ, de Silva MG, Okabe J, Wang L, Jones PL, Sif S, El-Osta A. Reply to "Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex". Nat Genet 2006;38(9):964-7. Harris D, Thomas M, Johnson D, Nicholls K, Gillin A; CARI. The CARI guidelines. Prevention of progression of kidney disease. Nephrology 2006;11 Suppl 1:S2-197. Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 2006;4(1):17-32. Head GA, Reid CM, Shiel LM, Jennings GL, Lukoshkova EV. Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens 2006;19(10):1010-7. Hengel CL, Russell PA, Gould PA, Kaye DM. Subacute anthracycline cardiotoxicity. Heart Lung Circ 2006;15(1):59-61. Henschke P, Vorum H, Honore B, Rice GE. Protein profiling the effects of in vitro hyperoxic exposure on fetal rabbit lung. Proteomics 2006;6(6):1957-62. Hilton DJ, Reid CM, Paratz J. An under-used yet easily understood statistic: the number needed to treat (NNT). Physiotherapy 2006;92(4): 240-6. Howes AL, Miyamoto S, Adams JW, Woodcock EA, Brown JH. Gαq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Gαq mediated hypertrophy. J Mol Cell Cardiol 2006;40(5):597-604. Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 2006;33(1-2):1-8. Inglis S, Stewart S. Metabolic therapeutics in angina pectoris: history revisited with perhexiline. Eur J Cardiovasc Nurs 2006;5(2):175-84. Inglis SC, Pearson S, Treen S, Gallasch T, Horowitz JD, Stewart S. Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care. Circulation 2006;114(23):2466-2473. Jaarsma T, Stromberg A, De Geest S, Fridlund B, Heikkila J, Martensson J, Moons P, Scholte op Reimer W, Smith K, Stewart S, Thompson DR. Heart failure management programmes in Europe. Eur J Cardiovasc Nurs 2006;5(3):197-205. Jandeleit-Dahm K. Does the risk of developing diabetes in hypertensive kidney disease vary with different antihypertensive agents? Nat Clin Pract Nephrol Jandeleit-Dahm K, Cooper ME. Hypertension and diabetes: role of the renin-angiotensin system. Endocrinol Metab Clin North Am 2006;35(3):469-90. Jandeleit-Dahm KA. Dual ACE/NEP inhibitors - more than playing the ACE card. J Hum Hypertens 2006;20(7):478-81. Jennings G. Autonomic neuropathy and the heart. Diabetes Management 2006;14:16-7. Joubert J, Reid C, Joubert L, Barton D, Ruth D, Jackson D, Sullivan JO, Davis SM. Risk factor management and depression post-stroke: the value of an integrated model of care. J Clin Neurosci 2006;13(1):84-90. Kahri J, Soro-Paavonen A, Ehnholm C, Taskinen MR. ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. Mediators Inflamm 2006;2006(3):12587. Kalinina NI, Bobik A, Tkachuk VA. Participation of the DNA-binding cytokine amphoterine in triggering the processes of tissue reparation. Ross Fiziol Zh Im I M Sechenova 2006;92(1):39-48. Kanellakis P, Slater NJ, Du XJ, Bobik A, Curtis DJ. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc Res 2006;70(1):117-25. Karagiannis T, El-Osta A. Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer. Epigenetics 2006;1(3):121-6. Karagiannis TC, El-Osta A. Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 2006;25(28):3885-93. Karagiannis TC, El-Osta A. The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation. Cell Cycle 2006;5(3):288-95. Karagiannis TC, Harikrishnan KN, El-Osta A. The epigenetic modifier, valproic acid, enhances radiation sensitivity. Epigenetics 2006;1(3):131-7. Kawaguchi M, Masuo K, Katsuya T, Rakugi H, Ogihara T, Tuck ML. β2- and β3-adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertens Res 2006;29(12):951-9. Kaye DM, Esler MD. Letter by Kaye and Esler regarding article "Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart". Circulation 2006;113(22):e844. Kemp W, Chin-Dusting J. Selective intestinal decontamination in portal hypertension. Gastroenterol Hepatol 2006;2(1):64-7. Kingwell BA, Anderson GP, Duckett SJ, Hoole EA, Jackson Pulver LR, Khachigian LM, Morris ME, Roder D, Rothell-Short J, Wilson AJ. Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth. Med J Aust 2006;184(6):282-6. Kistler PM, Earley MJ, Harris S, Abrams D, Ellis S, Sporton SC, Schilling RJ. Validation of three-dimensional cardiac image integration: use of integrated CT image into electroanatomic mapping system to perform catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006;17(4):341-8. 100. Kistler PM, Liew G, Mond HG. Long-term performance of active-fixation pacing leads: a prospective study. Pacing Clin Electrophysiol 2006;29(3):226-30. 101. Kistler PM, Rajappan K, Jahngir M, Earley MJ, Harris S, Abrams D, Gupta D, Liew R, Ellis S, Sporton SC, Schilling RJ. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006;17(10):1093-101. 102. Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll 103. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 2006;27(24):3045- 104. Konstantakopoulos N, Montgomery KG, Chamberlain N, Quinn MA, Baker MS, Rice GE, Georgiou HM, Campbell IG. Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog 2006;45(10):752-63. 105. Krum H, Jelinek M, Stewart S, Sindone A, Atherton J, Hawkes A on behalf of the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Chronic Heart Failure Clinical Practice Guidelines Expert Writing Panel. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust 2006;185(10):549-57. 106. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circul Physiol 2006;290(4):H1706-12. 107. Krum H, Stewart S. Chronic heart failure: time to recognize this major public health problem. Med J Aust 2006;184(4):147-8. 108. Kurokawa K, Chan JC, Cooper ME, Keane WF, Shahinfar S, Zhang Z. Renin angiotensin aldosterone system blockade and renal disease in patients with Type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study. Clin Exp Nephrol 2006;10(3):193-200. 109. Lambert E, Hotchkin E, Alvarenga M, Pier C, Richards J, Barton D, Dawood T, Esler M, Lambert G. Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol 2006;570(3):637-43. 110. Lambert G, Elam M, Friberg P, Lundborg C, Gao S, Berquist J, Nitescu P. Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck. J Physiol 2006;570(2):421-8. 111. Lanzafame AA, Turnbull L, Amiramahdi F, Arthur JF, Huynh H, Woodcock EA. Inositol phospholipids localized to caveolae in rat heart are regulated by α1- adrenergic receptors and by ischemia/reperfusion. Am J Physiol Heart Circul Physiol 2006;290(5):H2059-65. 112. Lappas M, Permezel M, Rice GE. 15-deoxy-Δ12,14-prostaglandin J2 and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta 2006;27(11-12):1060-72. 113. Lappas M, Yee K, Permezel M, Rice GE. Lipopolysaccharide and TNF-α activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta 2006;27(6-7):568-75. 114. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 2006;72(1):112-23. 115. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 116. Lekgabe ED, Royce SG, Hewitson TD, Tang ML, Zhao C, Moore XL, Tregear GW, Bathgate RA, Du XJ, Samuel CS. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of non-reproductive organs. Endocrinology 2006;147(12):5575-83. 117. Lenzen M, Scholte op Reimer W, Norekval TM, De Geest S, Fridlund B, Heikkila J, Jaarsma T, Martensson J, Moons P, Smith K, Stewart S, Stromberg A, Thompson DR, Wijns W. Pharmacological treatment and perceived health status during 1- year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization. Eur J Cardiovasc Nurs 2006;5(2):115-21. 118. Lessard SJ, Chen ZP, Watt MJ, Hashem M, Reid JJ, Febbraio MA, Kemp BE, Hawley JA. Chronic rosiglitazone treatment restores AMPKα2 activity in insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 2006;290(2):E251-7. 119. Li D, Weisinger HS, Weisinger RS, Mathai M, Armitage JA, Vingrys AJ, Sinclair AJ. Omega 6 to omega 3 fatty acid imbalance early in life leads to persistent reductions in DHA levels in glycerophospholipids in rat hypothalamus even after long-term omega 3 fatty acid repletion. Prostaglandins Leukot Essent Fatty Acids 2006;74(6):391-9. 120. Lu J, Moochhala S, Moore XL, Ng KC, Tan MH, Lee LK, He B, Wong MC, Ling EA. Adult bone marrow cells differentiate into neural phenotypes and improve functional recovery in rats following traumatic brain injury. Neurosci Lett 2006;398(1-2):12-7. 121. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, Smith TJ, Tsalamandris C, Hao H, Matthews PG, Thomas MC, Power DA, Jerums G. Is nonalbuminuric renal insufficiency in Type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 2006;29(7):1560-6. 122. MacIsaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 2006;49(7):1686-9. 123. Mariani JA, Gould PA, Broughton A, Kaye DM. Cardiac resynchronisation therapy for heart failure. Intern Med J 2006;36(2):114-23. 124. Masedunskas A, King JA, Tan F, Cochran R, Stevens T, Sviridov D, Ofori-Acquah SF. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. FEBS Lett 2006;580(11):2637-45. 125. Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML. β2- Adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. Am J Hypertens 2006;19(10):1084-91. 126. Mayorov DN. Does coffee reinforce the vascular inflammatory response to mental stress? J Hypertens 2006;24(11):2149-51. 127. McAllen RM, Farrell M, Johnson JM, Trevaks D, Cole L, McKinley MJ, Jackson G, Denton DA, Egan GF. Human medullary responses to cooling and rewarming the skin: a functional MRI study. Proc Natl Acad Sci USA 2006;103(3):809-13. 128. McConell GK, Kingwell BA. Does nitric oxide regulate skeletal muscle glucose uptake during exercise? Exerc Sport Sci Rev 2006;34(1):36-41. 129. McKinley MJ, Denton DA, Thomas CJ, Woods RL, Mathai ML. Differential effects of aging on fluid intake in response to hypovolemia, hypertonicity, and hormonal stimuli in Munich Wistar rats. Proc Natl Acad Sci USA 2006;103(9):3450-5. 130. McLennan SN, Pearson SA, Cameron J, Stewart S. Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a difference? Eur J Heart Fail 2006;8(5):494-501. 131. McMullen JR, Izumo S. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. Novartis Found Symp 2006;274:90-111. 132. McMurray JJ, Andersson FL, Stewart S, Svensson K, Solal AC, Dietz R, Vanhaecke J, van Veldhuisen DJ, Ostergren J, Granger CB, Yusuf S, Pfeffer MA, Swedberg K. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 133. Menshikov M, Torosyan N, Elizarova E, Plakida K, Vorotnikov A, Parfyonova Y, Stepanova V, Bobik A, Berk B, Tkachuk V. Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. J Vasc Res 134. Meyer RP, Hagemeyer CE, Knoth R, Kaufmann MR, Volk B. Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J Neurochem 2006;96(2):460-72. 135. Moons P, Scholte op Reimer W, De Geest S, Fridlund B, Heikkila J, Jaarsma T, Martensson J, Smith K, Stewart S, Stromberg A, Thompson DR; Undertaking Nursing Interventions Throughout Europe Research Group. Nurse specialists in adult congenital heart disease: the current status in Europe. Eur J Cardiovasc Nurs 2006;5(1):60-7. 136. Morris JB, Huynh H, Vasilevski O, Woodcock EA. α1-Adrenergic receptor signaling is localized to caveolae in neonatal rat cardiomyocytes. J Mol Cell Cardiol 2006;41(1):17-25. 137. Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D. Human Immunodeficiency Virus impairs reverse cholesterol transport from macrophages. 138. Murphy AJ, Sviridov D, Chin-Dusting JPF. Lipids and the endothelium: an update . 139. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 2006;27(1):96-106. 140. Murphy NF, Stewart S, Hart CL, Macintyre KP, Hole D, McMurray JJ. A population study of the long-term consequences of Rose angina: 20 year follow-up of the Renfrew-Paisley study. Heart 2006;92(12):1739-46. 141. Naredi S, Lambert G, Friberg P, Zall S, Eden E, Rydenhag B, Tylman M, Bengtsson A. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med 2006;32(12):1955-61. 142. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006;185(9):487-9. 143. Nestel P. Relationship between arterial stiffness and glucose metabolism in women with metabolic syndrome. Clin Exp Pharmacol Physiol 2006;33(9):883-6. 144. Nestel PJ, Fujii A, Allen T. The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 2006;189(2):282-7. 145. Nigro J, Osman N, Dart AM, Little PJ. Insulin resistance and atherosclerosis. 146. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, Mas JL, Richard AJ, Rother J, Wilson PW; REACH Registry Investigators. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 2006;151(4):786.e1-10. 147. Oto T, Calderone A, Pepe S, Snell G, Rosenfeldt F. High-flow endobronchial cooled humidified air protects non-heart-beating donor rat lungs against warm ischemia. J Thorac Cardiovasc Surg 2006;132(2):413-9. 148. Owen AJ, Reid CM. Prevention and treatment of atherothrombosis: the role of primary care. Int Rev Throm 2006;1(3):45-52. 149. Palliser HK, Hirst JJ, Rice GE, Ooi GT, Dellios NL, Escalona RM, Young IR. Labor- associated regulation of prostaglandin E and F synthesis and action in the ovine amnion and cervix. J Soc Gynecol Investig 2006;13(1):19-24. 150. Pearson S, Inglis SC, McLennan SN, Brennan L, Russell M, Wilkinson D, Thompson DR, Stewart S. Prolonged effects of a home-based intervention in patients with chronic illness. Arch Intern Med 2006;166(6):645-50. 151. Pettersson-Fernholm K, Fröjdö S, Fagerudd J, Thomas MC, Forsblom C, Wessman M, Groop PH; FinnDiane Study Group. The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in Type I diabetic patients. Kidney 152. Pfleger KD, Dromey JR, Dalrymple MB, Lim EM, Thomas WG, Eidne KA. Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal 2006;18(10):1664-70. 153. Pinnamaneni SK, Southgate RJ, Febbraio MA, Watt MJ. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vivo. Diabetologia 2006;49(12):3027-37. 154. Pittaway JK, Ahuja KD, Cehun M, Chronopoulos A, Robertson IK, Nestel PJ, Ball MJ. Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men. Ann Nutr Metab 2006;50(6):512-8. 155. Plekhanova OS, Stepanova VV, Ratner EI, Bobik A, Tkachuk VA, Parfyonova YV. Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation. J Vasc Res 2006;43(5):437-46. 156. Policha A, Daneshtalab N, Chen L, Dale LB, Altier C, Khosravani H, Thomas WG, Zamponi GW, Ferguson SS. Role of angiotensin II type 1A receptor phosphorylation, phospholipase D, and extracellular calcium in isoform-specific protein kinase C membrane translocation responses. J Biol Chem 2006;281(36):26340-9. 157. Prelovsek O, Mars T, Jevsek M, Podbregar M, Grubic Z. High dexamethasone concentration prevents stimulatory effects of TNF-α and LPS on IL-6 secretion from the precursors of human muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2006;291(6):R1651-6. 158. Preovolos AC, Mennen MT, Bilney A, Mariani J, Kaye DM, Power JM. Development of a novel perfusion technique to allow targeted delivery of gene therapy--the V- Focus system. J Extra Corpor Technol 2006;38(1):51-2. 159. Raj T, Kanellakis P, Pomilio G, Jennings G, Bobik A, Agrotis A. Inhibition of fibroblast growth factor receptor attenuates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006;26(8):1845-51. 160. Reid CM, Nelson MR. Optimising the management of hypertension. Med Prog 161. Rice GE, Georgiou HM, Ahmed N, Shi G, Kruppa G. Translational proteomics: developing a predictive capacity – A Review. Placenta 2006;27(Suppl A):S76-86. 162. Ritchie RH, Delbridge LM. Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clin Exp Pharmacol Physiol 2006;33(1-2):159-66. 163. Ritchie RH, Zeitz CJ, Wuttke RD, Hii JTY, Horowitz JD. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans - comparison with sotalol and verapamil. J Am Coll Cardiol 2006;48(6):1234-41. 164. Roberts MA, Thomas MC, Fernando D, Macmillan N, Power DA, Ierino FL. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol Dial Transplant 2006;21(6):1611-7. 165. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia I: clinical features, diagnosis, mechanisms, and anatomic location. Pacing Clin Electrophysiol 2006;29(6):643-52. 166. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia II: management. Pacing Clin Electrophysiol 2006;29(7):769-78. 167. Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. 168. Rosenfeldt F. Sir Brian Barratt-Boyes: a giant in cardiothoracic surgery in Australasia-will we see his like in the future? Heart Lung Circ 2006;15(5):289-90. 169. Rossing P, Cooper ME, Parving HH. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in Type 2 diabetes. Diabetes Care 2006;29(3):748. 170. Samuel CS, Du XJ, Bathgate RA, Summers RJ. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol Ther 2006;112(2):529-52. 171. Schäufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int 2006;70(6):1177-81. 172. Schmidt BM, Sammer U, Fleischmann I, Schlaich M, Delles C, Schmieder RE. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension 2006;47(4):650-5. 173. Scholte op Reimer WJ, Moons P, De Geest S, Fridlund B, Heikkila J, Jaarsma T, Lenzen M, Martensson J, Norekval TM, Smith K, Stewart S, Stromberg A, Thompson DR. Cardiovascular risk estimation by professionally active cardiovascular nurses: results from the Basel 2005 Nurses Cohort. Eur J Cardiovasc Nurs 2006;5(4):258-63. 174. Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K. Conformation-specific blockade of the integrin GPIIb/IIIa. A novel antiplatelet strategy that selectively targets activated platelets. Circ Res 2006;99(1):25-33. 175. Shaw JA, White AJ, Reddy R, Duffy SJ, Walton AS, Kingwell BA, Dart AM. Evaluation of differences in coronary plaque mechanical behaviour in individuals with and without Type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2006;26(12):2826-7. 176. Sheeran F, Pepe S. Energy deficiency in the failing heart: linking increased reactive oxygen species and disruption of oxidative phosphorylation rate. Biochim Biophys Acta Bioenergetics 2006;1757(5-6):543-52. 177. Smith NJ, Luttrell LM. Signal switching, crosstalk, and arrestin scaffolds: novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension 2006;48(2):173-9. 178. Soldatos G, Cooper ME. Advanced glycation end products and vascular structure and function. Curr Hypertens Rep 2006;8(6):472-8. 179. Soro-Paavonen A, Forbes JM. Novel therapeutics for diabetic micro- and macrovascular complications. Curr Med Chem 2006;13(15):1777-88. 180. Soro-Paavonen A, Westerbacka J, Ehnholm C, Taskinen MR. Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL. Ann Med 2006;38(3):229-38. 181. Srivastava PM, Thomas MC, Calafiore P, MacIsaac RJ, Jerums G, Burrell LM. Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clin Sci 2006;110(1):109-16. 182. Steinberg GR, Macaulay SL, Febbraio MA, Kemp BE. AMPK-the fat controller of the energy railroad. Can J Physiol Pharmacol 2006;84(7):655-65. 183. Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE. Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 2006;4(6):465- 184. Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA, Kemp BE. Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 2006;147(8):3906-14. 185. Steinberg GR, Watt MJ, McGee SL, Chan S, Hargreaves M, Febbraio MA, Stapleton D, Kemp BE. Reduced glycogen availability is associated with increased AMPKα2 activity, nuclear AMPKα2 protein abundance, and GLUT4 mRNA expression in contracting human skeletal muscle. Appl Physiol Nutr Metab 2006;31(3):302-12. 186. Stewart S. Review: multidisciplinary interventions reduce hospital admission and all cause mortality in heart failure. Evid Based Nurs 2006;9(1):23. 187. Stewart S. Review: routine changes of IV administration sets (not containing lipids or blood products) at intervals 96 hours do not affect infusate or catheter related bloodstream infection. Evid Based Nurs 2006;9(3):81. 188. Stewart S, McMurray JJ. Chilling findings: the need for winter vigilance in heart failure. J Card Fail 2006;12(2):120-1. 189. Stewart S, Murphy NF, McMurray JJ, Jhund P, Hart CL, Hole D. Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: an analysis of the Renfrew/Paisley Study. Eur J Heart Fail 2006;8(8):856-63. 190. Stewart S, Sliwa K. An African approach chronic heart failure management. SA 191. Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane L, McMurray JJ, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol 2006;108(1):101-8. 192. Stocker R, Pollicino C, Gay CA, Nestel P, Colquhoun D, Whiting M, Tonkin A, Sullivan D, Simes J. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. Atherosclerosis 2006;187(1):198-204. 193. Sviridov D, Chin-Dusting J, Nestel P, Kingwell B, Hoang A, Olchawa B, Starr J, Dart A. Elevated HDL cholesterol is functionally inefficient in cardiac transplant recipitents; evidence for impaired reverse cholesterol transport. Transplantation 2006;81(3):361-6. 194. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Gross M, Dietz R, Friedrich MG. Elective percutaneous coronary intervention acutely impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 2006;151(4):891.e1-7. 195. Thomas MC. The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiency. Semin Nephrol 2006;26(4):275-82. 196. Thomas MC, Atkins RC. Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs 2006;66(17):2213-34. 197. Thomas MC, Cooper ME, Rossing K, Parving HH. Anaemia in diabetes: is there a rationale to TREAT? Diabetologia 2006;49(6):1151-7. 198. Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH. Serum lipids and the progression of nephropathy in Type 1 diabetes. Diabetes Care 2006;29(2):317-22. 199. Thomas MC, Tsalamandris C, MacIsaac R, Jerums G. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Diabet Med 2006;23(5):502-9. 200. Thomas MC, Tsalamandris C, MacIsaac RJ, Jerums G. The epidemiology of hemoglobin levels in patients with Type 2 diabetes. Am J Kidney Dis 2006;48(4):537-45. 201. Thomas MC, Weekes AJ, Broadley OJ, Cooper ME. The assessment of kidney function by general practitioners in Australian patients with Type 2 diabetes (NEFRON-2). Med J Aust 2006;185(5):259-62. 202. Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH. The burden of chronic kidney disease in Australian patients with Type 2 diabetes (the NEFRON study). Med J Aust 2006;185(3):140-4. 203. Thomas MC, Zimmet P, Shaw JE. Identification of obesity in patients with Type 2 diabetes from Australian primary care: the NEFRON-5 study. Diabetes Care 2006;29(12):2723-5. 204. Tikellis C, Cooper ME, Thomas MC. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. Int J Biochem 205. Tikellis C, Thomas MC, Bialkowski K, Johnston CI, Burns WC, Lew RA, Smith AI, Cooper ME. Developmental expression of angiotensin converting enzyme 2 in the rodent kidney; a role in hypertension? Kidney Int 2006;70(1):34-41. 206. Turpin SM, Lancaster GI, Darby I, Febbraio MA, Watt MJ. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab 2006;291(6):E1341-50. 207. van den Brink OW, Rowland MA, Marasco SF, Esmore DS, Rosenfeldt FL, Pepe S. Complex regional pain syndrome and methionine-enkephalin. Clin Chem 2006;52(3):535. 208. Van Doornum S, Jennings GLR, Wicks IP. Reducing the cardiovascular disease burden in rheumatoid arthritis. Med J Aust 2006;184(6):287-90. 209. Vaz Patto MC, Skiba B, Pang ECK, Ochatt SJ, Lambein F, Rubiales D. Lathyrus improvement for resistance against biotic and abiotic stresses: from classical breeding to marker assisted selection. Euphytica 2006;147(1-2):133-47. 210. von zur Muhlen C, Peter K, Spreer J, Beyersdorf F, Pache G, Bode C, Handke M. Evidence of a steal phenomenon by a thoracic side branch of an internal mammary artery bypass. J Vasc Interv Radiol 2006;17(10):1714-5. 211. Walker A, McMurray J, Stewart S, Berger W, McMahon AD, Dargie H, Fox K, Hillis S, Henderson NJK, Ford I. Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart 2006;92(5):619-24. 212. Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, Carling D, Kemp BE, Febbraio MA, Steinberg GR. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 2006;12(5):541-8. 213. Watt MJ, Hevener A, Lancaster GI, Febbraio MA. Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 2006;147(5):2077-85. 214. Watt MJ, Holmes AG, Pinnamaneni SK, Garnham AP, Steinberg GR, Kemp BE, Febbraio MA. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 2006;290(3):E500-8. 215. Watt MJ, Steinberg GR, Chen ZP, Kemp BE, Febbraio MA. Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes. J Physiol 2006;574(Pt 1):139-47. 216. Watts G, Chan D, Ooi E, Nestel P, Beilin Lj, Barrett P. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. Clin Exp Pharmacol Physiol 217. Williamson M, Woollard KJ, Griffiths HR, Coombes AG. Gravity spun polycaprolactone fibers for applications in vascular tissue engineering: proliferation and function of human vascular endothelial cells. Tissue Eng 2006;12(1):45-51. 218. Winkelmayer WC, Zhang Z, Shahinfar S, Cooper ME, Avorn J, Brenner BM. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care 2006;29(10):2210-7. 219. Wluka AE. Remember the titanic: what we know of knee osteoarthritis is but the tip of the iceberg. J Rheumatol 2006;33(11):2110-2. 220. Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin-Dusting J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 2006;98(1):149-56. 221. Woollard KJ, Loryman CJ, Meredith E, Griffiths HR. α-Tocopherol supplementation does not affect monocyte endothelial adhesion or C-reactive protein levels but reduces soluble vascular adhesion molecule-1 in the plasma of healthy subjects. Redox Rep 2006;11(5):214-22. 222. Woollard KJ, Nesbitt W, Stugeon S, Harper I, Jackson S. Visualizing thrombus formation in vivo: current limitations and future prospects. Int Rev Throm 2006; 1(1):34-42. 223. Xu Q, Xu N, Zhang T, Zhang H, Li Z, Yin F, Lu Z, Han Q, Zhang Y. Mammalian tolloid alters subcellular localization, internalization, and signaling of α1a- adrenergic receptors. Mol Pharmacol 2006;70(2):532-41. 224. Yallop J, Chan B, Piterman L, Tonkin A, Forbes A, Davidson PM, Clark R, Halcomb E, Nangle A, Stewart S, Croucher J, Krum H, on behalf of the CHAT Study Group. The Chronic Heart-failure Assistance by Telephone (CHAT) study: assessment of telephone support for vulnerable patients with chronic disease. Asia Pacific Family Medicine 2006;5(2):. 225. Yan BP, Ajani AE, Duffy SJ, New G, Horrigan M, Szto G, Walton A, Eccleston D, Lefkovits J, Black A, Sebastian M, Brennan AL, Reid CM, Clark DJ. Use of drug- eluting stents in Victorian public hospitals. Med J Aust 2006;185(7):363-7. 226. Yang Z, Kaye DM. Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects. Trends Cardiovasc Med 2006;16(4):118-24. 227. Yap CH, Reid C, Yii M, Rowland MA, Mohajeri M, Skillington PD, Seevanayagam S, Smith JA. Validation of the EuroSCORE model in Australia. Eur J Cardiothorac Surg 2006;29(4):441-6. 228. Yap KS, Gould P, Kalff V, Kaye DM, Esmore D, Kelly MJ. Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging. J Heart Lung Transplant 2006;25(8):977-80. 229. Zhang WZ, Kaye DM. Does arginase activity in vitro represent that in vivo? 230. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability. Role of arginine metabolism and oxidative stress. Hypertension 2006;48(2):278-85. 231. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Response to cigarettes and ADMA: the smoke hasn't cleared yet. Hypertension 2006;48(4):E21. 232. Zimanyi MA, Denton KM, Forbes JM, Thallas-Bonke V, Thomas MC, Poon F, Black JM. Developmental nephron deficit is associated with increased susceptibility to secondary renal injury due to Advanced Glycation End-products (AGEs). Diabetologia 2006;49(4):801-10. 233. Stewart S, Inglis S, Hawkes A. Chronic Cardiac Care: a Practical Guide to Specialist Nurse Management. 2006. Blackwell BMJ Books, USA. Book Chapters
234. El-Osta A. Mechanisms of abnormal gene expression in tumor cells. In: Bignold LP (ed) Cancer: Cell Structures, Carcinogens and Genomic Stability. 2006. Birkhäuser Verlag, Germany. pp351-61. 235. Kingwell BA. Statins and arterial stiffness. In: Safar ME, O’Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp559-66. 236. Kingwell BA, Cameron JD. Non-pharmacological treatment for increased arterial stiffness. In: Safar ME, O’Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp567-80. 237. Lancaster GI, Febbraio MA. Exercise-induced increase in heat shock proteins - implications for metabolic diseases. In: Radons J, Multhoff G (eds) Heat Shock Proteins in Biology and Medicine. 2006. Research Signpost, India. pp295-303. 238. Rosenfeldt FL, Marasco S, Leong JY, Pepe S. Oxidative stress and coenzyme Q10 therapy. In: Singh KK (ed) Oxidative Stress, Disease and Cancer. 2006. Imperial College Press, UK. 239. Safar ME, Kass D, Asmar R, Kingwell BA. Basis for a de-stiffening strategy of antihypertensive drugs. In: Safar ME, O’Rourke ME (eds) Handbook of Hypertension: Arterial Stiffness in Hypertension, Vol 23. 2006. Elsevier, UK. pp527-36.

Source: http://ro.bakeridi.edu.au/performance/BHRI%20Publications%202006.pdf